TFEB and atherosclerosis: Trehalose induces autophagy through lysosomal mediated TFEB (Jeong et al., 2021), which can be used as a new drug choice for treating atherosclerosis (Evans et al., 2018), Motoneuron degeneration (Rusmini et al., 2019), cardiac remodeling (Sciarretta et al., 2018) and other diseases.